The cell cryopreservation market size has grown exponentially in recent years. It will grow from $15.68 billion in 2025 to $19.42 billion in 2026 at a compound annual growth rate (CAGR) of 23.9%. The growth in the historic period can be attributed to expansion of biobanking activities, increasing use of preserved cells in research, growth of IVF and fertility clinics, adoption of cryopreservation in regenerative medicine, availability of liquid nitrogen storage systems.
The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $41.82 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to increasing demand for cell and gene therapies, rising investments in biopharmaceutical manufacturing, expansion of stem cell research, growing focus on standardized storage protocols, increasing adoption of automated cryostorage systems. Major trends in the forecast period include increasing adoption of serum-free cryopreservation media, rising use of controlled-rate freezing systems, growing demand for long-term cell storage solutions, expansion of cryobanking infrastructure, enhanced focus on cell viability preservation.
The rising number of organ transplantation procedures is anticipated to drive the growth of the cell cryopreservation market in the coming years. Organ transplantation is a surgical procedure in which a diseased or non-functioning organ is replaced with a healthy organ obtained from a donor. The number of organ transplant procedures is increasing due to a growing incidence of organ failure resulting from hereditary disorders, infections, injuries, and chronic illnesses. In organ transplantation, cell cryopreservation involves the freezing and storage of organ-derived cells to maintain their viability for future use, improve graft outcomes, and minimize immune rejection. For instance, in January 2024, according to the Health Resources and Services Administration, a US-based federal agency, 46,632 organ transplants were performed in 2023 using organs from both living and deceased donors, representing an 8.7% increase compared to 2022. Therefore, the growing volume of organ transplantation procedures is fueling the expansion of the cell cryopreservation market.
Major companies operating in the cell cryopreservation market are concentrating on the development of advanced solutions, such as specialized cryopreservation media, to enhance long-term cell stability, ensure high-quality storage, and improve downstream therapeutic applications. Cryopreservation media are scientifically engineered formulations designed to protect cells or tissues at ultra-low temperatures while preserving their viability, functionality, and consistency for research and clinical processes. For instance, in April 2024, Pluristyx Inc., a US-based provider of tools, technologies, and services for cellular therapies, introduced PluriFreeze, a proprietary cryopreservation medium developed to accelerate advancements in stem cell therapies. Designed to support the expansion of induced pluripotent stem cells (iPSCs), the PluriFreeze Cryopreservation Media, intended for Research Use Only (RUO), provides an innovative approach to enhancing efficiency and quality during iPSC therapy development. This solution is aimed at simplifying stem cell research and supporting the commercialization of next-generation cell therapies, thereby reinforcing progress in the cell cryopreservation market.
In April 2023, Discovery Life Sciences, a US-based provider of biospecimen solutions and services, acquired ReachBio Research Labs for an undisclosed sum. Through this acquisition, Discovery Life Sciences seeks to broaden its preclinical and clinical research capabilities, strengthen its biologics testing services, accelerate drug development timelines, and enhance its overall service offerings. ReachBio Research Labs is a US-based contract research organization (CRO) specializing in cell-based assays.
Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., ThermoGenesis Holdings Inc., Akron Biotech, X-Therma Inc., Acorn Biolabs Inc., PanTHERA CryoSolutions, CryoCrate LLC, Chart Industries Inc., Eppendorf SE, PHC Holdings Corporation, Helmer Scientific Inc., Brooks Automation Inc., Azenta Life Sciences Inc., Worthington Industries Inc., CBS Scientific, Planer PLC, Stirling Ultracold Inc.
North America was the largest region in the cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cell cryopreservation market by increasing costs of imported cryogenic equipment, freezing media, cryovials, storage tanks, and temperature monitoring systems. Biopharmaceutical companies and research institutes in North America and Europe are most affected due to reliance on imported precision equipment, while Asia-Pacific faces higher infrastructure costs for cryobanks. These tariffs are raising capital investment requirements and extending installation timelines. However, they are also driving domestic manufacturing of cryogenic systems and local formulation of freezing media, strengthening regional supply chains.
The cell cryopreservation market research report is one of a series of new reports that provides cell cryopreservation market statistics, including cell cryopreservation industry global market size, regional shares, competitors with a cell cryopreservation market share, detailed cell cryopreservation market segments, market trends and opportunities, and any further data you may need to thrive in the cell cryopreservation industry. This cell cryopreservation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cell cryopreservation refers to the technique of preserving cells by lowering their temperature to sub-zero levels, most commonly using liquid nitrogen at around -196 °C. This approach completely stops biological activity and metabolic processes, enabling long-term storage of cells without deterioration. Cryoprotective agents are applied to inhibit the formation of ice crystals that could otherwise harm cellular structures during the freezing and thawing processes.
The primary products used in cell cryopreservation include cell freezing media, equipment, and consumables. Equipment consists of specialized instruments, such as controlled-rate freezers or isopropanol-based containers, designed to freeze cells at regulated speeds. This process is applied to cell types such as hepatocytes, stem cells, oocytes and embryonic cells, sperm cells, and others. It is offered to end users including biopharmaceutical and pharmaceutical companies, research institutes, biobanks, in vitro fertilization (IVF) clinics, and others.
The cell cryopreservation market consists of sales of cryoprotectants, freezing containers, and cryogenic storage systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $41.82 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to increasing demand for cell and gene therapies, rising investments in biopharmaceutical manufacturing, expansion of stem cell research, growing focus on standardized storage protocols, increasing adoption of automated cryostorage systems. Major trends in the forecast period include increasing adoption of serum-free cryopreservation media, rising use of controlled-rate freezing systems, growing demand for long-term cell storage solutions, expansion of cryobanking infrastructure, enhanced focus on cell viability preservation.
The rising number of organ transplantation procedures is anticipated to drive the growth of the cell cryopreservation market in the coming years. Organ transplantation is a surgical procedure in which a diseased or non-functioning organ is replaced with a healthy organ obtained from a donor. The number of organ transplant procedures is increasing due to a growing incidence of organ failure resulting from hereditary disorders, infections, injuries, and chronic illnesses. In organ transplantation, cell cryopreservation involves the freezing and storage of organ-derived cells to maintain their viability for future use, improve graft outcomes, and minimize immune rejection. For instance, in January 2024, according to the Health Resources and Services Administration, a US-based federal agency, 46,632 organ transplants were performed in 2023 using organs from both living and deceased donors, representing an 8.7% increase compared to 2022. Therefore, the growing volume of organ transplantation procedures is fueling the expansion of the cell cryopreservation market.
Major companies operating in the cell cryopreservation market are concentrating on the development of advanced solutions, such as specialized cryopreservation media, to enhance long-term cell stability, ensure high-quality storage, and improve downstream therapeutic applications. Cryopreservation media are scientifically engineered formulations designed to protect cells or tissues at ultra-low temperatures while preserving their viability, functionality, and consistency for research and clinical processes. For instance, in April 2024, Pluristyx Inc., a US-based provider of tools, technologies, and services for cellular therapies, introduced PluriFreeze, a proprietary cryopreservation medium developed to accelerate advancements in stem cell therapies. Designed to support the expansion of induced pluripotent stem cells (iPSCs), the PluriFreeze Cryopreservation Media, intended for Research Use Only (RUO), provides an innovative approach to enhancing efficiency and quality during iPSC therapy development. This solution is aimed at simplifying stem cell research and supporting the commercialization of next-generation cell therapies, thereby reinforcing progress in the cell cryopreservation market.
In April 2023, Discovery Life Sciences, a US-based provider of biospecimen solutions and services, acquired ReachBio Research Labs for an undisclosed sum. Through this acquisition, Discovery Life Sciences seeks to broaden its preclinical and clinical research capabilities, strengthen its biologics testing services, accelerate drug development timelines, and enhance its overall service offerings. ReachBio Research Labs is a US-based contract research organization (CRO) specializing in cell-based assays.
Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., ThermoGenesis Holdings Inc., Akron Biotech, X-Therma Inc., Acorn Biolabs Inc., PanTHERA CryoSolutions, CryoCrate LLC, Chart Industries Inc., Eppendorf SE, PHC Holdings Corporation, Helmer Scientific Inc., Brooks Automation Inc., Azenta Life Sciences Inc., Worthington Industries Inc., CBS Scientific, Planer PLC, Stirling Ultracold Inc.
North America was the largest region in the cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cell cryopreservation market by increasing costs of imported cryogenic equipment, freezing media, cryovials, storage tanks, and temperature monitoring systems. Biopharmaceutical companies and research institutes in North America and Europe are most affected due to reliance on imported precision equipment, while Asia-Pacific faces higher infrastructure costs for cryobanks. These tariffs are raising capital investment requirements and extending installation timelines. However, they are also driving domestic manufacturing of cryogenic systems and local formulation of freezing media, strengthening regional supply chains.
The cell cryopreservation market research report is one of a series of new reports that provides cell cryopreservation market statistics, including cell cryopreservation industry global market size, regional shares, competitors with a cell cryopreservation market share, detailed cell cryopreservation market segments, market trends and opportunities, and any further data you may need to thrive in the cell cryopreservation industry. This cell cryopreservation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cell cryopreservation refers to the technique of preserving cells by lowering their temperature to sub-zero levels, most commonly using liquid nitrogen at around -196 °C. This approach completely stops biological activity and metabolic processes, enabling long-term storage of cells without deterioration. Cryoprotective agents are applied to inhibit the formation of ice crystals that could otherwise harm cellular structures during the freezing and thawing processes.
The primary products used in cell cryopreservation include cell freezing media, equipment, and consumables. Equipment consists of specialized instruments, such as controlled-rate freezers or isopropanol-based containers, designed to freeze cells at regulated speeds. This process is applied to cell types such as hepatocytes, stem cells, oocytes and embryonic cells, sperm cells, and others. It is offered to end users including biopharmaceutical and pharmaceutical companies, research institutes, biobanks, in vitro fertilization (IVF) clinics, and others.
The cell cryopreservation market consists of sales of cryoprotectants, freezing containers, and cryogenic storage systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cell Cryopreservation Market Characteristics
3. Cell Cryopreservation Market Supply Chain Analysis
4. Global Cell Cryopreservation Market Trends and Strategies
5. Cell Cryopreservation Market Analysis of End Use Industries
7. Global Cell Cryopreservation Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cell Cryopreservation Total Addressable Market (TAM) Analysis for the Market
9. Cell Cryopreservation Market Segmentation
10. Cell Cryopreservation Market Regional and Country Analysis
11. Asia-Pacific Cell Cryopreservation Market
12. China Cell Cryopreservation Market
13. India Cell Cryopreservation Market
14. Japan Cell Cryopreservation Market
15. Australia Cell Cryopreservation Market
16. Indonesia Cell Cryopreservation Market
17. South Korea Cell Cryopreservation Market
18. Taiwan Cell Cryopreservation Market
19. South East Asia Cell Cryopreservation Market
20. Western Europe Cell Cryopreservation Market
21. UK Cell Cryopreservation Market
22. Germany Cell Cryopreservation Market
23. France Cell Cryopreservation Market
24. Italy Cell Cryopreservation Market
25. Spain Cell Cryopreservation Market
26. Eastern Europe Cell Cryopreservation Market
27. Russia Cell Cryopreservation Market
28. North America Cell Cryopreservation Market
29. USA Cell Cryopreservation Market
30. Canada Cell Cryopreservation Market
31. South America Cell Cryopreservation Market
32. Brazil Cell Cryopreservation Market
33. Middle East Cell Cryopreservation Market
34. Africa Cell Cryopreservation Market
36. Cell Cryopreservation Market Competitive Landscape and Company Profiles
37. Cell Cryopreservation Market Other Major and Innovative Companies
40. Cell Cryopreservation Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Cell Cryopreservation Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cell cryopreservation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell cryopreservation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell cryopreservation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Cell Freezing Media; Equipment; Consumables2) By Application: Hepatocytes; Stem Cells; Oocytes And Embryotic cells; Sperm Cells; Other Applications
3) By End-Use Channel: Biopharmaceutical And Pharmaceutical Companies; Research Institutes; Biobanks; In Vitro Fertilization (IVF) Clinics; Other End-Use Channels
Subsegments:
1) By Cell Freezing Media: Serum-Based Freezing Media; Serum-Free Freezing Media2) By Equipment: Cryopreservation Freezers; Cryo Storage Tanks; Controlled-Rate Freezers
3) By Consumables: Cryovials; Cryo Storage Bags; Cryo Tubes
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Corning Inc.; STEMCELL Technologies; Cryoport Inc.; ThermoGenesis Holdings Inc.; Akron Biotech; X-Therma Inc.; Acorn Biolabs Inc.; PanTHERA CryoSolutions; CryoCrate LLC; Chart Industries Inc.; Eppendorf SE; PHC Holdings Corporation; Helmer Scientific Inc.; Brooks Automation Inc.; Azenta Life Sciences Inc.; Worthington Industries Inc.; CBS Scientific; Planer PLC; Stirling Ultracold Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cell Cryopreservation market report include:- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Merck KGaA
- Corning Inc.
- STEMCELL Technologies
- Cryoport Inc.
- ThermoGenesis Holdings Inc.
- Akron Biotech
- X-Therma Inc.
- Acorn Biolabs Inc.
- PanTHERA CryoSolutions
- CryoCrate LLC
- Chart Industries Inc.
- Eppendorf SE
- PHC Holdings Corporation
- Helmer Scientific Inc.
- Brooks Automation Inc.
- Azenta Life Sciences Inc.
- Worthington Industries Inc.
- CBS Scientific
- Planer PLC
- Stirling Ultracold Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 19.42 Billion |
| Forecasted Market Value ( USD | $ 41.82 Billion |
| Compound Annual Growth Rate | 21.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
